Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,237,010 | 1,238,459 | 2,715,411 | 1,990,683 | 1,958,633 |
| Marketable Securities | 3,148,825 | 3,264,692 | 2,171,480 | 3,155,825 | 3,428,021 |
| Other current assets | 125,811 | 112,600 | 113,173 | 217,460 | 414,465 |
| TOTAL | $4,511,646 | $4,615,751 | $5,000,064 | $5,363,968 | $5,801,119 |
| Non-Current Assets | |||||
| PPE Net | 25,667 | 14,865 | 12,056 | 13,563 | 13,674 |
| Investments And Advances | 412,315 | 283,814 | 302,939 | 290,040 | 311,354 |
| Other Non-Current Assets | 112,970 | 118,172 | 121,881 | 124,774 | 79,881 |
| TOTAL | $550,952 | $416,851 | $436,876 | $428,377 | $404,909 |
| Total Assets | $5,062,598 | $5,032,602 | $5,436,940 | $5,792,345 | $6,206,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,064 | 11,550 | 23,691 | 23,712 | 25,127 |
| Accrued Expenses | 108,315 | 88,728 | 114,294 | 104,324 | 111,469 |
| Other current liabilities | 1,476 | 4,186 | 1,584 | 3,613 | 8,921 |
| TOTAL | $133,857 | $113,866 | $149,411 | $141,484 | $556,249 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 175,803 | 153,386 | 146,231 | 166,197 | 119,477 |
| TOTAL | $123,283 | $102,830 | $100,331 | $114,891 | $69,737 |
| Total Liabilities | $257,140 | $216,696 | $249,742 | $256,375 | $625,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 695,492 | 682,882 | 679,806 | 713,549 | 727,950 |
| Retained earnings | -429,107 | -315,588 | 116,060 | 460,398 | 395,580 |
| Other shareholders' equity | 462,685 | 487,409 | 509,031 | 354,555 | 409,051 |
| TOTAL | $4,805,458 | $4,815,906 | $5,187,198 | $5,535,970 | $5,580,042 |
| Total Liabilities And Equity | $5,062,598 | $5,032,602 | $5,436,940 | $5,792,345 | $6,206,028 |